DNA methylation biomarkers-based method for the differential diagnosis of multiple lung cancers
Open Access
- 15 April 2026
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 216, 109415
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82073121)
- National Natural Science Foundation of China (82371847)
- National Natural Science Foundation of China (82203451)
This publication has 35 references indexed in Scilit:
- Genomic characteristics and immune landscape of super multiple primary lung cancerEBioMedicine, 2024
- Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-originCancer Cell, 2023
- A novel NGS‐based diagnostic algorithm for classifying multifocal lung adenocarcinomas in pN0M0 patientsThe Journal of Pathology: Clinical Research, 2022
- Patient and Nodule Characteristics Associated With a Lung Cancer Diagnosis Among Individuals With Incidentally Detected Lung NodulesChest, 2022
- Long-Term Prognosis of Patients With Resected Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma of the LungJournal of Thoracic Oncology, 2021
- A multidisciplinary approach for the differential diagnosis between multiple primary lung adenocarcinomas and intrapulmonary metastasesPathology - Research and Practice, 2021
- A novel cell‐free DNA methylation‐based model improves the early detection of colorectal cancerMolecular Oncology, 2021
- Screening for Lung Cancer With Low-Dose Computed TomographyJAMA, 2021
- Using Genomics to Differentiate Multiple Primaries From Metastatic Lung CancerJournal of Thoracic Oncology, 2019
- Proposal for a Combined Histomolecular Algorithm to Distinguish Multiple Primary Adenocarcinomas from Intrapulmonary Metastasis in Patients with Multiple Lung TumorsJournal of Thoracic Oncology, 2019